论文部分内容阅读
目的：探究低分子肝素、阿司匹林联合辛伐他汀治疗不稳定型心绞痛的临床疗效，为后期临床治疗提供参考。方法选取我院2010年3月至2011年1月期间门诊收入的心绞痛患者90例作为研究对象，根据治疗方式的不同分为研究组与对照组各45例。研究组采用低分子肝素、阿司匹林联合辛伐他汀治疗，对照组给予常规治疗。观察两组患者经治疗后的一般情况。结果两组患者经治疗后在心绞痛发作次数、持续时间、临床总有效率、总不良反应比较，差异具有统计学意义（P＜0．05）。结论低分子肝素、阿司匹林联合辛伐他汀对不稳定心绞痛的临床治疗效果显著，安全性高，副作用少，值得进一步推广及应用。“,”objective to explore the low molecular heparin and aspirin with simvastatin therapy the clinical ef ect of the treatment of unstable angina,and provide reference for clinical treatment.Methods select our hospital during March 2010 to January 2010 outpatient service revenue of 90 cases of angina pectoris patients as the research object,according to the dif erent meth-ods of treatment is divided into research group and the control group (n =45 ).The team with low molecular heparin and aspirin with simvastatin therapy,the control group given conventional treatment.To observe the general situation of two groups of patients after treatment.Results two groups of patients after treatment in the at ack frequency of angina pectoris,duration,clinical total efective rate and total adverse reactions,statistical y significant diference (P <0.05).Conclusion low molecular heparin and aspirin in combination with simvastatin on unstable angina pectoris clinical treatment ef ect significantly,high safety,less side ef ects and is worth further promotion and application.